|
Volumn 66, Issue 12, 2006, Pages
|
Chronic migraine and medication-overuse headache
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE;
ANALGESIC AGENT;
ANTIEMETIC AGENT;
BUTALBITAL;
BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL;
CAFERGOT;
CELECOXIB;
DIHYDROERGOTAMINE;
ERGOT ALKALOID;
NARCOTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
TRIPTAN DERIVATIVE;
DISABILITY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG INDUCED HEADACHE;
DRUG WITHDRAWAL;
HEADACHE;
HUMAN;
INCIDENCE;
NAUSEA;
NOTE;
PHONOPHOBIA;
PHOTOPHOBIA;
PHYSICAL ACTIVITY;
PRIORITY JOURNAL;
RISK FACTOR;
TENSION HEADACHE;
TRANSFORMED MIGRAINE;
CHEMICALLY INDUCED DISORDER;
CHRONIC DISEASE;
DOCTOR PATIENT RELATION;
DOSE RESPONSE;
DRUG ADMINISTRATION;
METHODOLOGY;
MIGRAINE;
RISK ASSESSMENT;
SECONDARY HEADACHE;
TREATMENT OUTCOME;
TREATMENT WITHDRAWAL;
ANALGESICS;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HEADACHE DISORDERS, SECONDARY;
HUMANS;
MIGRAINE DISORDERS;
PHYSICIAN-PATIENT RELATIONS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
WITHHOLDING TREATMENT;
|
EID: 33745907248
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000227588.24559.89 Document Type: Article |
Times cited : (4)
|
References (1)
|